![Irvin Choo](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Irvin Choo
Private-Equity-Analyst bei
DW Healthcare Partners (Canada)
Profil
Irvin Choo is currently working as a Vice President at DW Healthcare Partners (Canada).
He started this position in 2022.
Prior to this, he obtained an MBA from The University of Waterloo in 2019.
Aktive Positionen von Irvin Choo
| Unternehmen | Position | Beginn |
|---|---|---|
DW Healthcare Partners (Canada)
 DW Healthcare Partners (Canada) Investment ManagersFinance DW Healthcare Partners invests exclusively in healthcare companies. The firm's deal origination team develops and maintains relationships with thousands of business owners and identifies hundreds of potential investment opportunities annually. They actively pursue add-on acquisition opportunities for their partners which have proven to be an edge on growth in every competitive market. They target North American companies with EBITDA of $4 million or more and strong historical growth rates. DW Healthcare prefers to take majority ownership but may consider minority positions. Equity investments range from $15 million to $40 million. | Private-Equity-Analyst | 01.07.2019 |
Ausbildung von Irvin Choo
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
88
Beziehungen ersten Grades
2
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
The University of Waterloo
 The University of Waterloo Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
DW Healthcare Partners (Canada)
DW Healthcare Partners (Canada) Investment ManagersFinance DW Healthcare Partners invests exclusively in healthcare companies. The firm's deal origination team develops and maintains relationships with thousands of business owners and identifies hundreds of potential investment opportunities annually. They actively pursue add-on acquisition opportunities for their partners which have proven to be an edge on growth in every competitive market. They target North American companies with EBITDA of $4 million or more and strong historical growth rates. DW Healthcare prefers to take majority ownership but may consider minority positions. Equity investments range from $15 million to $40 million. | Finance |
